A Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3-OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)

Authors :: Michael G. Ison
Alberto Papi
Joanne M. Langley
Dong-Dun Lee
Isabel Leroux-Roels
Federico Martinon-Torres
Tino F. Schwarz
Richard N. van Zyl-Smit
Nancy Dezutter
Nathalie De Schrevel
Laurence Fissette
Marie-Pierre David
Marie Van Der Wielen
Lusine Kostanyan
Veronica Hulstrøm
Source :: Diabetologie und Stoffwechsel.
Publication Year :: 2023
Publisher :: Georg Thieme Verlag, 2023.

Full Text Access

Tools